USP Reference Standards Catalog - Chroma Chemie

1 Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 1 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type1000408 Abacavir Sulfate (200 mg)R028L0F1L487 (31-DEC-2016)188062-50-2N/A$ Sulfate Racemic (20 mg) (4-[2-amino-6-(cyclopropylamino)-9H-puri n-9yl]-2-cyclopentene-1-methanol sulfate (2:1))F0G248188062-50-2N/A$ Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent -2-enyl]methanol)F1L311F0H284 (31-OCT-2013)124752-25-6N/A$ Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diami no-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2-enyl}-9H-purine-2,6-diamine) F0M143N/AN/A$ Last Updated On.

2 February 8, 2018 USP Reference Standards CatalogPage 2 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type1000441 Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-yla mino)cyclopent-2-enyl]methanol)F1L318F0H 283 (31-OCT-2013)N/AN/A$ Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9 -yl)cyclopent-2-enyl]methanol hydrochloride)F1L322F0H285 (30-SEP-2013)172015-79-1N/A$ Related Compounds Mixture (15 mg)R077P0R039P0 (31-AUG-2018)N/AN/A$ Stereoisomers Mixture (15 mg)R077N0R044D0 (30-APR-2018)N/AN/A$ System Suitability Mixture (15 mg) (A mixture containingabacavir sulfate and trans-R066P0F0J097 (30-APR-2018)N/AN/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 3 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typeabacavir)1000521 Acarbose (200 mg) (COLD SHIPMENT REQUIRED)F0M16056180-94-0N/A$ System Suitability Mixture (2 mg) (COLD SHIPMENT REQUIRED)F0L204N/AN/A$ Calcium (200 mg)F0M48477337-73-6N/A$ Related Compound A (15 mg) (3-aminopropane-1-sulfonic acid)F0M4993687-18-1N/A$ Related Compound B (20 mg)F04090N/AN/A$ Hydrochloride (125 mg)F005N2F-1 (31-JUL-2015)34381-68-5N/A$ Last Updated On.

3 February 8, 2018 USP Reference Standards CatalogPage 4 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type1000612 Acebutolol Related Compound A (20 mg) (N-(3-acetyl-4-hydroxyphenyl) butanamide)F1G041F0G041 (31-JUL-2015)40188-45-2N/A$ Related Compound B (20 mg) (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylam ino)propoxy]phenyl}acetamide)F005G022568 -64-5N/A$ Related Compound I (20 mg) (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxy propoxy]phenyl}butyramide)F005H0441019-9 1-6N/A$ Acetate (200 mg)F029L0154229-18-2N/A$ System SuitabilityR065J0F01710 (31-DEC-2018)N/AN/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 5 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer TypeMixture (20 mg)1001003 Acenocoumarol (200 mg)G0D300 (31-JAN-2019)152-72-7N/A$ Maleate (250 mg)R003N0F-2 (31-OCT-2015)3598-37-6N/A$ Potassium (200 mg)G0H082F0C136 (30-JUN-2009)55589-62-3N/A$ (3 mL)F037R0 (30-NOV-2018)75-07-0N/A$ (400 mg)K2M244K0I244 (30-APR-2017)103-90-2N/A$ Related Compound A (15 mg) (4-(acetylamino)phenyl acetate)F0J2522623-33-8N/A$ Related Compound B (30 mg) (N-(4-hydroxyphenyl)propanamide)R066W0R0 12P0 (28-FEB-2019)1693-37-4N/A$ Related R00920F1M247 (31-AUG-2015)614-80-2N/A$ Last Updated On.

4 February 8, 2018 USP Reference Standards CatalogPage 6 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer TypeCompound C (50 mg) (N-(2-hydroxyphenyl)acetamide)1003042 Acetaminophen Related Compound D (50 mg) (N-phenylacetamide)R01300F0L221 (30-SEP-2016)103-84-4N/A$ Related Compound F (50 mg) (p-nitrophenol)F0M236100-02-7N/A$ Related Compound J (50 mg) (N-(4-chlorophenyl)acetamide)R00310F0L22 2 (31-JUL-2015)539-03-7N/A$ Melting Point Standard (1g) (Approximately 114 degrees)M1M285M0A029 (30-SEP-2014)103-84-4N/A$ (2 K1J032K0J032 (31-MAY-59-66-5N/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 7 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typeg)2017)1005048 Acetazolamide Related Compound D (25 mg) (5-Amino-1,3,4-thiadiazole-2-sulfonamide )F025E014949-00-9N/A$ Related Compound E (25 mg) (5-Acetamido-1,3,4-thiadiazole-2-sulfoni c acid potassium salt)F025H0N/AN/A$ Acetic Acid ( mL/ampule; 3 ampules)R038A0I0M342 (31-JUL-2017)64-19-7N/A$ (250 mg)HG-1 (30-JUN-1999)968-81-0N/A$ Acid (200 mg)F-1F (31-MAR-2003)546-88-3N/A$ ( mL/ampule.)

5 3 ampules)I0M548H0K208 (31-MAR-2017)67-64-1N/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 8 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type1008002 Propoxyphene Related Compound B (50 mg) (alpha-d-2- acetoxy -4-dimethylamino-1,2-d iphenyl-3-methylbutane)I0I291H0D012 (30-NOV-2011)53990-51-5N/A$ Chloride (200 mg)R023K0H0F091 (30-SEP-2015)60-31-1N/A$ (200 mg)K0K294J0I282 (30-NOV-2012)616-91-1N/A$ (1 g)F0K3071122-62-9N/A$ Citrate (3 x 200 mg)R053A0H0I337 (31-AUG-2017)77-90-7N/A$ Citrate (500 mg)R041M0H0I339 (31-JAN-2017)77-89-4N/A$ ,L-Methionine (100 mg)F035801115-47-5N/A$ (200 mg)F0L5127512-17-6N/A$ Last Updated On.

6 February 8, 2018 USP Reference Standards CatalogPage 9 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type1010081N-Acetyl-L-Leucine (100 mg) (Acetyl-L-leucine)F046G01188-21-2N/A$ (100 mg)F0I085537-55-3N/A$ Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acet oxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl }-3,7-dimethyl-1,2,3,7,8,8a-hexahydronap hthalen-1-yl 2,2-dimethylbutanoate)F00660145576-25-6N /A$ (200 mg)R04460F0E266 (31-JAN-2017)55079-83-9N/A$ Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-F0E264 69427-46-9N/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 10 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typetrimethylphenyl)-3,7-dimethylnona-2, 4,6,8-tetraenoic acid)1011029 Acitretin Related Compound B (20 mg) (ethyl (all-E)-9-(4-methoxy-2,3,6-trimethylphen yl)-3,7-dimethylnona-2,4,6,8-tetraenoate )F0E26554350-48-0N/A$ (200 mg)R03020F0L117 (31-JUL-2016)106685-40-9N/A$ Related Compound A (50 mg) (Methyl 6-bromo-2-naphthoate)F0K41833626-98-1N/A $ Related Compound B (50 mg) (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-F0K4 19106685-41-0N/A$ Last Updated On.)

7 February 8, 2018 USP Reference Standards CatalogPage 11 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type2-naphthoate)1011732 Adapalene Related Compound C (25 mg) (2-(adamant-1-yl)methoxybenzene)R065K0F0 L078 (31-DEC-2017)43109-77-9N/A$ Related Compound D (25 mg) (4,4'-dimethoxy-3,3'-di(adamant-1-yl)bip henyl)R07140F0L079 (31-MAR-2018)932033-57-3N/A$ Related Compound E (25 mg) (2,2'-binaphthyl-6,6'-dicarboxylic acid)R066R0F0L080 (30-SEP-2017)932033-58-4N/A$ Hydrochloride (25mg) (3',4'-Dihydroxy-2-(methylamino)acetophe none F032A062-13-5N/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 12 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typehydrochloride)1011889 Advantame (200 mg)F034R0714229-20-6N/A$ Acid (20 mg) (N-[N-[3-(3-hydroxy-4-methoxyphenyl)prop yl]aspartyl]phenylalanine)F034S0713524-9 5-9N/A$ (20 mg)F0H26418642-44-9N/A$ Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6, 9-dihydro-1H-purin-2-yl]acetamide)F1M502 F0L515 (29-FEB-2016)110104-37-5N/A$ (300 mg)K0L516J1G366 (31-MAY-2015)59277-89-3N/A$ Related Compound A (50 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin- 9-yl)methoxy]ethylR023H0I0M125 (31-JUL-2016)102728-64-3N/A$ Last Updated On.

8 February 8, 2018 USP Reference Standards CatalogPage 13 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typeacetate)1012087 Acyclovir Related Compound G (50 mg) (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9 H-purin-9-yl]methoxy}ethyl acetate)F0L51075128-73-3N/A$ (200 mg)R068R0I0M090 (31-AUG-2018)73-24-5N/A$ (50mg)R02130F0G241 (30-SEP-2016)979-92-0N/A$ (200 mg)I0M365H0J390 (31-JUL-2015)58-61-7N/A$ Disulfate Tosylate(500 mg) (S-Adenosyl-L-Methionine Disulfate Tosylate)F0D07397540-22-2N/A$ (25 mg)F55332-76-8N/A$ '-Adenylic Acid F0J20461-19-8N/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 14 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type(500 mg)1012190 Adipic Acid (100 mg)F1D318F0D318 (31-MAR-2018)124-04-9N/A$ (25 mg)R081S0F0D397 (11-DEC-2017)11027-63-7N/A$1, (500 mg)F0K137N/AN/A$ Alanine (100mg)R033Y0F0F111 (31-AUG-2016)107-95-9N/A$ (200 mg)R06030H0M400 (30-APR-2018)56-41-7N/A$ (200 mg)F004H039537-23-0N/A$ (200 mg)F0M2251948-31-8N/A$ (200 mg)R02690H1K275 (30-NOV-2015)54965-21-8N/A$ Human (6 mg) (Recombinant Human Albumin) (COLD SHIPMENT REQUIRED)R04600G0M268 (31-DEC-2016)N/AN/A$ Shipment Required1012600 Albuterol (200 mg)IH (31-DEC-2000)18559-94-9N/A$ Last Updated On.

9 February 8, 2018 USP Reference Standards CatalogPage 15 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Type1012633 Albuterol Sulfate (200 mg)K0G284J (28-FEB-2009)51022-70-9N/A$ Related Compound A (25 mg) (4-[2-[(1,1-dimethylethyl)amino]-1-hydro xyethyl]-2-methylphenol sulfate)F0H22318910-68-4N/A$ Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hyd roxymethyl)phenyl]ethanone)F0M123156547- 62-5N/A$ Determination--Alcohol (5 mL/ampule; 5 ampules)G0M024 (31-OCT-2018)64-17-5N/A$ Related Compound E (10 mg) (2,2'-oxybis(methylene)bis{4-[2-(tert-F0 M127N/AN/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 16 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typebutylamino)-1-hydroxyethyl]phenol} diacetate)1012699 Alcohol Determination--AcetonitrileF0C419N/AN/A$ Dipropionate Related Compound A (20 mg) (11beta,17,21-trihydroxy-16alpha-methylp regna-1,4-diene-3,20-dione 17,21-dipropionate)F0K017N/AN/A$ Dipropionate (300mg)R044G0I0C302 (31-DEC-2018)66734-13-2N/A$ ( mL/ampule; 5 ampules)R087W0G0L460 (31-OCT-2018)64-17-5N/A$ Alcohol ( mL/ampule.)

10 5 G0M292F0D031 (31-JUL-2015)64-17-5N/A$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 17 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer Typeampules)1012780 Alendronate Sodium (200 mg)H0H004G0D288 (31-AUG-2009)121268-17-5N/A$ Acid (50 mg)F02300533-87-9N/A$ (250 mg)F0J25999016-42-9 (hydrate); 80863-62N/A$ - Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-a lanimamide)F0M11980875-07-6N/A$ System Suitability Mixture A (25 mg) (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E)F0L107N/AN/A$ G1J037G0J037 (31-MAR-70879-28-0021697$ Last Updated On: February 8, 2018 USP Reference Standards CatalogPage 18 Catalog #DescriptionCurrent LotPrevious Lot(Valid Use Date)CAS #NDC #Unit PriceSpecial RestrictionContainer TypeHydrochloride CII (500 mg)2016